Aurinia Pharmaceuticals Inc (AUPH) Is Not Likely To Be The Same Tomorrow

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

Aurinia Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Aurinia Pharmaceuticals Inc is $759.44M. A total of 1.76 million shares were traded on the day, compared to an average of 2.03M shares.

In the most recent transaction, Greenleaf Peter sold 126,981 shares of AUPH for 5.60 per share on Mar 06 ’24. After the transaction, the Chief Executive Officer now owns 1,522,114 company shares. In a previous transaction on Mar 06 ’24, Robertson Stephen P. sold 57,745 shares at 5.60 per share. AUPH shares that EVP, General Counsel owns now total 443,824.

Among the insiders who sold shares, Donley Matthew Maxwell disposed of 40,665 shares on Mar 06 ’24 at a per-share price of $5.51. This resulted in the EVP, Ops & Strategy holding 584,072 shares of AUPH after the transaction. In another insider transaction, Miller Joseph M sold 34,811 shares at $5.60 per share on Mar 06 ’24. Company shares held by the Chief Financial Officer now total 495,928.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, AUPH has a high of $12.43 and a low of $4.71.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. AUPH’s latest balance sheet shows that the firm has $466.08M in Cash & Short Term Investments as of fiscal 2021. There were $8.74M in debt and $40.65M in liabilities at the time. Its Book Value Per Share was $2.50, while its Total Shareholder’s Equity was $479.09M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AUPH is Buy with a score of 4.43.

Most Popular

Related Posts